Skip to main content
Commentaries
About Us
Contact Us
Media Appearances
Follow Us
Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial
https://www.medrxiv.org/content/10.1101/2022.04.18.22271936v1
Dean Follmann et al.
medRvx
April 19, 2022
